• Blog
  • Allergy Diagnostic and Treatment Market Analysis | 2022-2028

    Allergy Diagnostic and Treatment Market Analysis | 2022-2028

    Allergy Diagnostic and Treatment Market Analysis | 2022-2028
    Report code - SR1574 Delivery - 2 Weeks
    Allergy Diagnostic and Treatment Market Size, Share, Trend, Forecast, & Competitive An See more...

    "The Allergy Diagnostic and Treatment Market is expected to grow from USD 34.98 billion in 2021 to USD 50.74 billion by 2028 at a CAGR of over 5.42% during the forecast period of 2022-2028".

    Allergy Diagnostic and Treatment Market Size

    Wish to get a free sample? Register Here

    Market Dynamics

    Introduction

    Allergies are abnormal immune system reactions to typically harmless substances in the environment. These substances, known as allergens, can trigger allergic reactions ranging from mild discomfort to severe, life-threatening symptoms. Allergy diagnostics and treatment aim to identify and manage these reactions effectively.

    Market Drivers

    The growth of the global allergy diagnostic and treatment market is primarily driven by an increasing number of people suffering from allergic diseases. The surging demand for in vitro diagnostic blood tests is likely to drive market growth at a significant rate during the review period. Additionally, rising investment in research and development activities to develop advanced allergy diagnostic solutions is likely to create lucrative opportunities for the players operating in the global market in the coming years.

    COVID-19 Impact on Allergy Diagnostic and Treatment Market

    The COVID-19 outbreak posed significant challenges for the healthcare sector across geographies. It impacted the growth of the allergy diagnostic and treatment market negatively as diagnostic procedures other than COVID-19 treatment were postponed or declined.

    Allergy Diagnostic and Treatment Market Snapshot

    Wish to get a free sample? 

    Segment Analysis

    End-User Trend

    "Hospitals' segment accounted for the largest market share in 2021"

    Based on end-users, the market has been segmented into diagnostic laboratories, hospitals, and academic research institutes. The hospitals' segment accounted for the largest market share in 2021 and is projected to register a significant CAGR during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure and skilled staff.

    Regional Trend

    "North America accounted for the largest market share in 2021"

    Geographically, the market in North America accounted for the largest market share in 2021 and is expected to register significant CAGR during the review period. The market growth can be attributed to the high demand for advanced allergy diagnostic solutions in the healthcare sector coupled with the presence of key market players such as Danaher Corporation (US) and Lincoln Diagnostics, LLC (US). The market in Asia-Pacific is expected to be driven by rising incidences of allergic diseases in developing countries, particularly China and India.

    Market Segmentation

    The market is segmented in the following ways:

    By Allergy Type

    • Inhaled Allergens
    • Food Allergens
    • Drug Allergens
    • Other Allergens

    By Diagnostic Tests Type

    • Specific IgE Testing
    • Patch Testing
    • Blood Testing
    • Others

    By Drug Class Type

    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Leukotrienes Inhibitors
    • Mast Cell inhibitors
    • Others

    By End-User Type

    • Diagnostic Laboratories
    • Hospitals
    • Academic Research Institutes

    By Region:

    • North America
    • Europe
    • Asia-Pacific
    • Middle East & Africa
    • South America

    Key Players

    The following are the key players in the Allergy Diagnostic And Treatment Market (arranged alphabetically)

    • BoMérieux SA (France)
    • Danaher Corporation (US)
    • HOB Biotech Group Corp., Ltd (China)
    • Hycor Biomedical (US)
    • Lincoln Diagnostics, LLC (US)
    • Omega Diagnostics Group (UK)
    • R-Biopharm AG (Germany)
    • Siemens AG (Germany)
    • Stallergenes Greer (UK).
    • Lincoln Diagnostics, LLC (US)
    • Thermo Fisher Scientific (US)

    Note: The above list does not necessarily include all the top players in the market.

    Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

    Report Features

    This report provides market intelligence most totally. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    in-depth Analysis of the Allergy Diagnostic and Treatment Market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    What are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The allergy diagnostic and treatment market is expected to witness an impressive growth of 5.42% CAGR in the coming years.

    BioMrieux SA (France), Danaher Corporation (US), Siemens AG (Germany), Omega Diagnostics Group (UK), R-Biopharm AG (Germany), Lincoln Diagnostics, LLC (US), Thermo Fisher Scientific (US), HOB Biotech Group Corp., Ltd (China), Hycor Biomedical (US) and Stallergenes Greer (UK) are among the key players in the allergy diagnostic and treatment market.

    The allergy diagnostic and treatment market size is expected to reach USD 50.74 billion in 2028.

    The hospitals' segment is expected to register significant CAGR in the allergy diagnostic and treatment market in the coming years.

    North America accounted for the largest share in the allergy diagnostic and treatment market in 2021.